HyperAIHyperAI

Command Palette

Search for a command to run...

morph Embeds AI in Materials to Build Learning Robot Cells

London-based morph officially emerged in early June 2026, introducing a platform that embeds artificial intelligence directly into flexible substrates to create modular soft robotic cells. Co-founded by Dr. Jean Nehme, a former reconstructive surgeon, the venture addresses a persistent clinical and engineering limitation: static orthotics and support products cannot adapt to changing human biomechanics. Nehme posits that physical intelligence must be intrinsic to the material rather than appended as a software layer. Diverging from traditional soft robotics that rely on pneumatic actuators or shape-memory alloys, morph develops programmable material units that concurrently manage structural support, sensing, actuation, and control. The platform operates on a hierarchical computing architecture designed for physical responsiveness. Lightweight signal processing and real-time control loops execute locally at the edge to guarantee minimal latency, while cloud infrastructure processes high-fidelity physics simulations and reinforcement learning model training. This simulation-to-reality pipeline enables rapid hardware iteration before physical deployment. Morph commercialization strategy initially targets consumer health and athletic performance applications to validate the technology outside stringent regulatory frameworks. The company explicitly engineers its adaptive algorithms to align with the FDA Predetermined Change Control Plan, ensuring that machine learning-driven modifications remain within pre-certified operational boundaries. This compliance strategy directly addresses a fundamental regulatory hurdle for continuously learning medical and consumer hardware. Operating as a B2B infrastructure provider, morph will partner with hardware manufacturers to integrate its smart cells into footwear, braces, automotive seating, and industrial equipment. The startup has secured undisclosed seed funding from investors including 8VC, Pharrell Williams, Copper, Equinox executive Harvey Spevak, Qubit Health Capital, Valia Ventures, and Blue Lion. The launch of morph underscores a critical structural gap in the physical AI sector. While the industry has heavily concentrated capital and engineering talent on robotic brains, foundational models, and rigid humanoid platforms, the material layer remains mechanically passive. By relocating intelligence to the adaptive substrate, morph challenges the prevailing hardware paradigm. Successful commercialization could redefine human-machine interaction, demonstrating that future physical intelligence depends as much on programmable matter as on computational algorithms.

Related Links